Fidji Simo, OpenAI's second-in-command executive, is transitioning to a part-time advisory role after a three-month medical leave, creating a significant leadership vacuum at the company just months before its planned initial public offering (IPO) targeting a $1 trillion valuation in 2027. Simo disclosed in a staff memo that she has lived with Postural Orthostatic Tachycardia Syndrome (POTS), a neuroimmune condition, for seven years and experienced a severe relapse in April 2026 that proved longer and harder to recover from than anticipated.

Why Does This Matter for OpenAI's IPO Plans?

Simo joined OpenAI in May 2025 as CEO of Applications, a newly created role reporting directly to Sam Altman that consolidated the company's product and business operations. Her departure removes the executive Altman specifically recruited to scale OpenAI's commercial operations into a revenue engine ahead of going public. OpenAI currently carries an $852 billion valuation and confidentially filed for an IPO last month. Losing a named business leader months before a public market debut creates real scrutiny risk, as investors will expect to see a clear operational structure and succession plan in place.

Simo's mandate had been to grow OpenAI's consumer and enterprise business at a critical moment. ChatGPT's consumer growth cooled late last year and missed internal revenue targets, pushing the company to lean harder into coding tools and enterprise software, areas where it continues to trail competitor Anthropic. The vacancy lands as OpenAI is reorganizing aggressively around core products and has shut down peripheral bets including Sora as part of a focus strategy.

What Was Simo's Role at OpenAI?

When Simo arrived, she built out a substantial reporting structure. Chief Operating Officer (COO) Brad Lightcap, Chief Financial Officer (CFO) Sarah Friar, and then-Chief Product Officer (CPO) Kevin Weil all reported to her, freeing Altman to focus on research, compute, and safety. However, that structure has since shifted. Weil has left the company, and Lightcap moved to a special-projects role around the same time Simo went on medical leave in April 2026. Chief Marketing Officer (CMO) Kate Rouch also departed that month to focus on cancer recovery.

Before joining OpenAI, Simo had built an impressive track record in scaling consumer and enterprise businesses. She spent over a decade at Meta, running the Facebook app from 2019 to 2021, then took Instacart public as CEO in 2023, breaking the longest tech IPO drought in three decades. She joined OpenAI's board of directors in March 2024 before Altman recruited her to run applications a year later.

Who Could Replace Simo, and What Are the Options?

One internal candidate positioned to expand her portfolio is Denise Dresser, who joined OpenAI as Chief Revenue Officer (CRO) in December 2025. Dresser previously spent two years as CEO of Slack and 14 years at Salesforce, giving her the enterprise pedigree OpenAI needs as it chases Anthropic in coding and business software. However, OpenAI's executive bench appears thin for a company of its valuation and ambitions.

President Greg Brockman has absorbed product strategy responsibilities during Simo's absence and is overseeing a reorganization that merges ChatGPT and Codex into a single agentic platform. But Brockman is already stretched across multiple pillars, including core product and platform, critical enterprise industries, consumer verticals like health and personal finance, and core infrastructure. The company needs a full-time operator over applications if the IPO narrative is going to hold up under public-market scrutiny.

How to Understand OpenAI's Broader Leadership Challenges

• Equity Acceleration: OpenAI shortened its vesting cliff from the industry-standard 12 months to 6 months in April 2025, then eliminated it entirely in December 2025, letting equity vest from day one. The company was projected to spend $6 billion on stock-based compensation in 2025 alone, reflecting how aggressively it is defending against poaching from Anthropic and Meta.
• Timing Pressure: Simo's departure comes months before a $1 trillion IPO attempt, leaving the company without a named business leader overseeing applications at a moment when public investors will scrutinize organizational depth and succession planning.
• Competitive Context: Anthropic is closing the enterprise gap in coding tools, and OpenAI's consumer growth has cooled, making the need for strong commercial leadership even more acute as the company prepares for public markets.

In her memo, Simo referenced turning down a full year of medical leave from Meta in 2021, writing that Mark Zuckerberg had told her to "play the long game" and that she wished she had listened. She said she spent her tenure at OpenAI postponing medical tests and new therapies to avoid missing work. Sam Altman responded on X, saying he was "really sad about this and very grateful for all fidji has done for openai, and even grateful for her friendship and who she is as a person".

Sam Altman

Simo will remain involved as an advisor but will not carry operational responsibility. Her departure underscores the human cost of the AI industry's accelerating pace and the challenge of building sustainable leadership structures at companies racing toward trillion-dollar valuations and public markets.